![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 53, 55578-55586, December 31, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B Family Proteins Participate in Multiple Steps of Hematopoiesis through Elimination of Reactive Oxygen Species*








From the
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, 2-2, Yamada-oka, Suita, Osaka 565-0871, Japan and the¶Stem Cell Biology Group, RIKEN Center for Development Biology, 2-2-3, Minatojima-minami-machi, Tyuo-ku, Kobe City, Hyogo 650-0047, Japan
To examine the roles for NF-
B family proteins in hematopoiesis, we first expressed dominant negative Rel/NF-
B(I
BSR) in a factor-dependent cell line, Ba/F3. Although I
BSR neither affected thrombopoietin-dependent nor gp130-mediated growth, it suppressed interleukin-3- and erythropoietin-dependent growth at low concentrations. In addition, I
BSR enhanced factor-deprived apoptosis through the accumulation of reactive oxygen species (ROS). When expressed in normal hematopoietic stem/progenitor cells, I
BSR induced apoptosis even in the presence of appropriate cytokines by accumulating ROS. We also expressed I
BSR in an inducible fashion at various stages of hematopoiesis using the OP9 system, in which hematopoietic cells are induced to develop from embryonic stem cells. When I
BSR was expressed at the stage of Flk-1+ cells (putative hemangioblasts), I
BSR inhibited the development of primitive hematopoietic progenitor cells by inducing apoptosis through the ROS accumulation. Furthermore, when I
BSR was expressed after the development of hematopoietic progenitor cells, it inhibited their terminal differentiation toward erythrocytes, megakaryocytes, and granulocytes by inducing apoptosis through the ROS accumulation. These results indicate that NF-
B is required for preventing apoptosis at multiple steps of hematopoiesis by eliminating ROS.
Received for publication, July 21, 2004 , and in revised form, September 27, 2004.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 81-6-6879-3871; Fax: 81-6-6879-3879; E-mail: matumura{at}bldon.med.osaka-u.ac.jp.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. D. Erusalimsky and S. Moncada Nitric Oxide and Mitochondrial Signaling: From Physiology to Pathophysiology Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2524 - 2531. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Naujokat and T. Saric Concise Review: Role and Function of the Ubiquitin-Proteasome System in Mammalian Stem and Progenitor Cells Stem Cells, October 1, 2007; 25(10): 2408 - 2418. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cilloni, G. Martinelli, F. Messa, M. Baccarani, and G. Saglio Nuclear factor {kappa}B as a target for new drug development in myeloid malignancies Haematologica, September 1, 2007; 92(9): 1224 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Panepucci, R. T. Calado, V. Rocha, R. Proto-Siqueira, W. A. Silva Jr., and M. A. Zago Higher Expression of Transcription Targets and Components of the Nuclear Factor-{kappa}B Pathway Is a Distinctive Feature of Umbilical Cord Blood CD34+ Precursors Stem Cells, January 1, 2007; 25(1): 189 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Um and H. F. Lodish Antiapoptotic Effects of Erythropoietin in Differentiated Neuroblastoma SH-SY5Y Cells Require Activation of Both the STAT5 and AKT Signaling Pathways J. Biol. Chem., March 3, 2006; 281(9): 5648 - 5656. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |